NxStage Medical, Inc.  

(Public, NASDAQ:NXTM)   Watch this stock  
Find more results for NXTM
+0.10 (0.51%)
After Hours: 19.85 0.00 (0.00%)
Nov 24, 4:40PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 19.31 - 19.87
52 week 13.47 - 21.10
Open 19.49
Vol / Avg. 236,870.00/585,988.00
Mkt cap 1.25B
P/E     -
Div/yield     -
EPS -0.28
Shares 63.73M
Beta 0.31
Inst. own 101%
Dec 1, 2015
NxStage Medical Inc at Piper Jaffray Healthcare Conference - 1:30PM EST - Add to calendar
Nov 18, 2015
NxStage Medical Inc at Jefferies Global Healthcare Conference
Nov 11, 2015
NxStage Medical Inc at Stephens Fall Investment Conference
Nov 10, 2015
NxStage Medical Inc at Credit Suisse Healthcare Conference
Nov 3, 2015
Q3 2015 NxStage Medical Inc Earnings Release
Nov 3, 2015
NxStage Medical Inc Financial Analyst Day & Third Quarter 2015 Earnings Call - Webcast
Sep 17, 2015
NxStage Medical Inc at Morgan Stanley Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -2.31% -8.06%
Operating margin -1.89% -7.36%
EBITD margin - 1.83%
Return on average assets -2.64% -7.89%
Return on average equity -3.60% -12.45%
Employees 3,400 -
CDP Score - -


350 Merrimack St
LAWRENCE, MA 01843-1748
United States - Map
+1-978-6874700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


NxStage Medical, Inc. is a medical device company. The Company is engaged in the development, manufacturing and marketing of products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. The Company’s products include the System One, Streamline Blood Tubing Sets and AV Fistula and Apheresis Needles. Its primary product, the System One, is a small, portable, easy-to-use hemodialysis system. It is designed to deliver the therapeutic flexibility and clinical benefits associated with traditional dialysis machines in a smaller, portable, easy-to-use form that can be used by healthcare professionals and trained lay users alike in a variety of settings, including patient homes, as well as more traditional care settings such as hospitals and dialysis centers. The Company operates in three reportable business segments: System One, In-Center and Services.

Officers and directors

Robert G. Funari Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Joseph E. Turk Jr. President
Age: 47
Bio & Compensation  - Reuters
Jeffrey H. Burbank Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Matthew W. Towse CPA, Chief Financial Officer, Senior Vice President
Age: 52
Bio & Compensation  - Reuters
Robert S Brown President of NxStage Kidney Care
Age: 56
Bio & Compensation  - Reuters
Winifred L. Swan J.D. Senior Vice President, General Counsel
Age: 50
Bio & Compensation  - Reuters
Daniel A. Giannini CPA, Independent Director
Age: 65
Bio & Compensation  - Reuters
Earl R. Lewis Independent Director
Age: 71
Bio & Compensation  - Reuters
Jean K. Mixer Independent Director
Age: 48
Bio & Compensation  - Reuters
Craig W. Moore Independent Director
Age: 70
Bio & Compensation  - Reuters